SBI Dividend Yield Fund
The scheme seeks to provide investors with opportunities for capital appreciation and/or dividend distribution by investing predominantly in a well-diversified portfolio of equity and equity related instruments of dividend yielding companies.
Growthvine rating: 2/5 — ranked #7 of 10 in category.
Fund basics
| Category | Equity: Dividend Yield |
|---|
| NAV | ₹14.95 (as of 2026-10-01) |
|---|
| AUM | ₹8,554 Cr |
|---|
| Expense ratio | 1.52% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Nidhi Chawla |
|---|
| Exit load | 1% for redemption within 30 days |
|---|
Performance & risk
| Sharpe ratio | 0.49 |
|---|
| Standard deviation | 13.89% |
|---|
| Max drawdown | −18.28% |
|---|
| Alpha | 0.66 |
|---|
| Beta | 0.88 |
|---|
Over 5 years, captured 79.6% of NIFTY Dividend Opportunities 50's upside and 67.7% of its downside.
Market cap allocation
| Large cap | 56.5% |
|---|
| Mid cap | 21.4% |
|---|
| Small cap | 22.2% |
|---|
Concentration
| Top 5 holdings | 20.7% |
|---|
| Top 10 holdings | 32.9% |
|---|
| Total holdings | 58 |
|---|
Top holdings
- ICICI Bank Ltd. — 6.9%
- TREPS — 4.3%
- Larsen & Toubro Limited — 3.9%
- LIFE INSURANCE CORPORATION OF INDIA — 3.8%
- ACME Solar Holdings Limited — 3.5%
- InterGlobe Aviation Limited — 2.6%
- EMBASSY OFFICE PARKS REIT — 2.5%
- Cholamandalam Investment and Finance Company Ltd — 2.5%
- Vedanta Aluminium Metal Limited — 2.4%
- Aurobindo Pharma Ltd. — 2.4%
Top sectors
- Pharma & Biotech — 10.6%
- Banking & Financial — 9.0%
- Automobile — 8.8%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −4.3% | Q1 (Top) | #3 of 9 |
| 2025 | 6.0% | Q1 (Top) | #3 of 9 |
| 2024 | 14.5% | Q4 (Bottom) | #8 of 9 |